Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma

Mario Castro(University of Kansas Medical Center), Ariel Teper(Insmed (United Kingdom))

New England Journal of Medicine

May 21, 2018

10.1056/nejmoa1804092

Cited by 1,900

Related Papers

Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program

|Journal of Allergy and Clinical Immunology|2007|933

Effectiveness and Safety of Bronchial Thermoplasty in the Treatment of Severe Asthma: A Multicenter, Randomized, Double-Blind, Sham-Controlled Clinical Trial

|American Journal of Respiratory and Critical Care Medicine|2009|686

Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial

|The Lancet|2015|566

Long-term Safety and Efficacy of Reslizumab in Patients with Eosinophilic Asthma

|The Journal of Allergy and Clinical Immunology In Practice|2017|146

Inflammatory and clinical risk factors for asthma attacks (ORACLE2): a patient-level meta-analysis of control groups of 22 randomised trials

|The Lancet Respiratory Medicine|2025|69